TY - JOUR
T1 - International survey on opinions and use of minimally invasive surgery in small bowel neuroendocrine neoplasms
AU - Kaçmaz, Enes
AU - Engelsman, Anton F.
AU - Bemelman, Willem A.
AU - Tanis, Pieter J.
AU - Nieveen van Dijkum, Elisabeth J. M.
AU - Serrablo, Alejandro
AU - Proud, David
AU - Mackrill, David
AU - Toth, Dezso
AU - Coetzee, Emile
AU - Bertani, Emilio
AU - van Ramshorst, Gabrielle H.
AU - Kroon, Hidde M.
AU - Hassan, Iyad
AU - Hennings, Joakim
AU - Muñoz de Nova, José Luis
AU - Daskalakis, Kosmas
AU - Brunaud, Laurent
AU - Puccini, Marco
AU - Matthey-Giè, Marie-Laure
AU - Katsamakas, Michail
AU - Norlen, Olov
AU - Stalberg, Peter
AU - Shina, Rebecca
AU - Ford, Samuel
AU - Jancewicz, Stephen
AU - Glyn, Tamara
AU - Obadiel, Yasser
AU - International Study Group of Small bowel neuroendocrine neoplasm Surgery (ISGSS)
AU - Özkan, Zeynep
N1 - Funding Information: The authors would like to thank the European Society of Endocrine Surgeons, European Neuroendocrine Tumour Society, Spanish Group of Neuroendocrine and Endocrine Tumours, German Society of Coloproctology, and the Colorectal Surgical Society of Australia and New Zealand and all of their members for filling in our survey. Publisher Copyright: © 2021 The Author(s)
PY - 2022/6
Y1 - 2022/6
N2 - Introduction: Although minimally invasive surgery is becoming the standard technique in gastrointestinal surgery, implementation for small bowel neuroendocrine neoplasms (SB-NEN) is lagging behind. The aim of this international survey was to gain insights into attitudes towards minimally invasive surgery for resection of SB-NEN and current practices. Methods: An anonymous survey was sent to surgeons between February and May 2021 via (neuro)endocrine and colorectal societies worldwide. The survey consisted of questions regarding experience of the surgeon with minimally invasive SB-NEN resection and training. Results: A total of 58 responses from five societies across 20 countries were included. Forty-one (71%) respondents worked at academic centers. Thirty-seven (64%) practiced colorectal surgery, 24 (41%) endocrine surgery and 45 (78%) had experience in advanced minimally invasive surgery. An open, laparoscopic or robotic approach was preferred by 23 (42%), 24 (44%), and 8 (15%) respondents, respectively. Reasons to opt for a minimally invasive approach were mainly related to peri-operative benefits, while an open approach was preferred for optimal mesenteric lymphadenectomy and tactile feedback. Additional training in minimally invasive SB-NEN resection was welcomed by 29 (52%) respondents. Forty-three (74%) respondents were interested in collaborating in future studies, with a cumulative median (IQR) annual case load of 172 (86–258). Conclusions: Among respondents, 69% applies minimally invasive surgery for resection of SB-NEN. Arguments for specific operative approaches differ, and insufficient training in advanced laparoscopic techniques seems to be a barrier. Future collaborative studies can provide better insight in selection criteria and optimal technique.
AB - Introduction: Although minimally invasive surgery is becoming the standard technique in gastrointestinal surgery, implementation for small bowel neuroendocrine neoplasms (SB-NEN) is lagging behind. The aim of this international survey was to gain insights into attitudes towards minimally invasive surgery for resection of SB-NEN and current practices. Methods: An anonymous survey was sent to surgeons between February and May 2021 via (neuro)endocrine and colorectal societies worldwide. The survey consisted of questions regarding experience of the surgeon with minimally invasive SB-NEN resection and training. Results: A total of 58 responses from five societies across 20 countries were included. Forty-one (71%) respondents worked at academic centers. Thirty-seven (64%) practiced colorectal surgery, 24 (41%) endocrine surgery and 45 (78%) had experience in advanced minimally invasive surgery. An open, laparoscopic or robotic approach was preferred by 23 (42%), 24 (44%), and 8 (15%) respondents, respectively. Reasons to opt for a minimally invasive approach were mainly related to peri-operative benefits, while an open approach was preferred for optimal mesenteric lymphadenectomy and tactile feedback. Additional training in minimally invasive SB-NEN resection was welcomed by 29 (52%) respondents. Forty-three (74%) respondents were interested in collaborating in future studies, with a cumulative median (IQR) annual case load of 172 (86–258). Conclusions: Among respondents, 69% applies minimally invasive surgery for resection of SB-NEN. Arguments for specific operative approaches differ, and insufficient training in advanced laparoscopic techniques seems to be a barrier. Future collaborative studies can provide better insight in selection criteria and optimal technique.
KW - Minimally invasive surgery
KW - Neuroendocrine neoplasms
KW - Survey
UR - http://www.scopus.com/inward/record.url?scp=85119661143&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.ejso.2021.11.011
DO - https://doi.org/10.1016/j.ejso.2021.11.011
M3 - Article
C2 - 34823919
SN - 0748-7983
VL - 48
SP - 1251
EP - 1257
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 6
ER -